Positron Emission Tomography Clinical Trials

13 recruiting

Positron Emission Tomography Trials at a Glance

13 actively recruiting trials for positron emission tomography are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Early Phase 1 with 3 trials, with the heaviest enrollment activity in Tianjin, Exeter, and Leuven. Lead sponsors running positron emission tomography studies include Tianjin Medical University, University of Exeter, and Huashan Hospital.

Browse positron emission tomography trials by phase

Treatments under study

About Positron Emission Tomography Clinical Trials

Looking for clinical trials for Positron Emission Tomography? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Positron Emission Tomography trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Positron Emission Tomography clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Early Phase 1

iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009

Huntington DiseasePositron Emission TomographyImaging+5 more
CHDI Foundation, Inc.27 enrolled1 locationNCT06634628
Recruiting

Serotonin Release in Premotor and Motor PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter42 enrolled1 locationNCT05516732
Recruiting

Longitudinal Investigation of I2BS in PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter44 enrolled1 locationNCT05516719
Recruiting
Phase 3

PSMA PET Combined With MRI for the Detection of PCa

Prostate CancerProstatic NeoplasmPCA+6 more
Telix Pharmaceuticals (Innovations) Pty Limited204 enrolled1 locationNCT07052214
Recruiting

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Prostate CancerMetastasisPositron Emission Tomography+2 more
Tianjin Medical University500 enrolled2 locationsNCT06690970
Recruiting
Phase 2Phase 3

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Pancreatic CancerFAPIPositron Emission Tomography+5 more
Turku University Hospital100 enrolled1 locationNCT07098598
Recruiting
Early Phase 1

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

Positron Emission Tomography
University of California, Davis12 enrolled1 locationNCT06453915
Recruiting

Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging

Alzheimer DiseasePositron Emission Tomography
Huashan Hospital3,000 enrolled1 locationNCT06827678
Recruiting
Early Phase 1

[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients

CancerPositron Emission TomographyStimulator of Interferon Gene
First Affiliated Hospital of Chongqing Medical University30 enrolled1 locationNCT06419361
Recruiting

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

MetastasisTumorPositron Emission Tomography+1 more
Tianjin Medical University500 enrolled1 locationNCT06690957
Recruiting

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

TumorPositron Emission TomographyGLP1-R-related Disease+1 more
Tianjin Medical University500 enrolled1 locationNCT06725693
Recruiting

FAPI PET/CT in Various FAP-Related Disease Patients

MetastasisTumorPositron Emission Tomography+1 more
Tianjin Medical University500 enrolled1 locationNCT06688071
Recruiting
Not Applicable

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

MetastasisTumorPositron Emission Tomography+1 more
Tianjin Medical University200 enrolled1 locationNCT06690736